Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of patients with advanced disease remains overall poor and their chance of cure is anecdotic. In a molecularly selected population, a median overall survival of 13.8 mo has been reached with the use of human epidermal growth factor 2 (HER2) inhibitors in combination with chemotherapy, which has soon after become the standard of care for patients with HER2-overexpressing GC. Moreover, oncologists have recognized the clinical utility of conceiving cancers as a collection of different molecularly-driven entities rather than a single disease. Several molecular drivers have been identified as having crucial roles in other tumors and new molecular classifications have been recently proposed for gastric cancer as well. Not only these classifications allow the identification of different tumor subtypes with unique features, but also they serve as springboard for the development of different therapeutic strategies. Hopefully, the application of standard systemic chemotherapy, specific targeted agents, immunotherapy or even surgery in specific cancer subgroups will help maximizing treatment outcomes and will avoid treating patients with minimal chance to respond, therefore diluting the average benefit. In this review, we aim at elucidating the aspects of GC molecular subtypes, and the possible future applications of such molecular analyses.

Molecular classifications of gastric cancers: Novel insights and possible future applications / Garattini, Silvio Ken; Basile, Debora; Cattaneo, Monica; Fanotto, Valentina; Ongaro, Elena; Bonotto, Marta; Negri, Francesca V; Berenato, Rosa; Ermacora, Paola; Cardellino, Giovanni Gerardo; Giovannoni, Mariella; Pella, Nicoletta; Scartozzi, Mario; Antonuzzo, Lorenzo; Silvestris, Nicola; Fasola, Gianpiero; Aprile, Giuseppe. - In: WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY. - ISSN 1948-5204. - STAMPA. - 9:(2017), pp. 194-208. [10.4251/wjgo.v9.i5.194]

Molecular classifications of gastric cancers: Novel insights and possible future applications

Antonuzzo, Lorenzo;
2017

Abstract

Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of patients with advanced disease remains overall poor and their chance of cure is anecdotic. In a molecularly selected population, a median overall survival of 13.8 mo has been reached with the use of human epidermal growth factor 2 (HER2) inhibitors in combination with chemotherapy, which has soon after become the standard of care for patients with HER2-overexpressing GC. Moreover, oncologists have recognized the clinical utility of conceiving cancers as a collection of different molecularly-driven entities rather than a single disease. Several molecular drivers have been identified as having crucial roles in other tumors and new molecular classifications have been recently proposed for gastric cancer as well. Not only these classifications allow the identification of different tumor subtypes with unique features, but also they serve as springboard for the development of different therapeutic strategies. Hopefully, the application of standard systemic chemotherapy, specific targeted agents, immunotherapy or even surgery in specific cancer subgroups will help maximizing treatment outcomes and will avoid treating patients with minimal chance to respond, therefore diluting the average benefit. In this review, we aim at elucidating the aspects of GC molecular subtypes, and the possible future applications of such molecular analyses.
9
194
208
Garattini, Silvio Ken; Basile, Debora; Cattaneo, Monica; Fanotto, Valentina; Ongaro, Elena; Bonotto, Marta; Negri, Francesca V; Berenato, Rosa; Ermacora, Paola; Cardellino, Giovanni Gerardo; Giovannoni, Mariella; Pella, Nicoletta; Scartozzi, Mario; Antonuzzo, Lorenzo; Silvestris, Nicola; Fasola, Gianpiero; Aprile, Giuseppe
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1287156
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 40
social impact